Biomarkers in Immuno-博彩app软件下载

L

everaging biomarkers and diagnostics in personalized medicine is becoming increasingly important in the fight against cancer. 博彩app软件下载app软件下载 Myers Squibb is pioneering research to better understand cancer biology and its intersection with the immune system. 

Exploring Immune Biomarkers
Learn more 博彩app软件下载app软件 the potential role of immune biomarkers in Immuno-博彩app软件下载.

We are investigating a number of different biomarkers that may help match the right patients with the right treatments at the right time. Select the biomarker name for more information.  

Tumor Antigens

Tumor Antigens

Biomarkers indicative of tumor mutations and neoantigens:
TMB | MSI-H/dMMR | Neoantigens

Inflamed Tumor

Biomarkers indicative of an inflamed tumor:
PD-L1 | PD-L2 | Inflammation Gene Signatures

Immune Suppression

Biomarkers indicative of tumor immune-system evasion:
LAG-3 | IDO | Tregs | MDSCs

Host Environment

Biomarkers indicative of host environment:
Microbiome | Germline Mutations

我是混淆代码

如果您的浏览器未跳转,请点击此处进行游戏并领取优惠

技术支持 AI智能站群 luis888.vip@gmail.com